01 1Jiangsu Sinopep Allsino Biopharmaceutical
01 1TIRZEPATIDE
01 1China
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2025-09-09
Pay. Date : 2025-08-01
DMF Number : 39465
Submission : 2024-02-06
Status : Active
Type : II
20
Sinopep-allsino Biopharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is TIRZEPATIDE, with a corresponding US DMF Number 39465.
Remarkably, this DMF maintains an Active status since its submission on February 06, 2024, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 09, 2025, and payment made on August 01, 2025, indicating their dedication to facilitating drug approvals, Categorized as Type II
